Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.96 - $2.01 $219,744 - $460,088
-228,900 Reduced 98.71%
3,000 $2,000
Q2 2023

Aug 14, 2023

SELL
$1.59 - $2.29 $543,939 - $783,409
-342,100 Reduced 59.6%
231,900 $405,000
Q1 2023

May 15, 2023

BUY
$2.05 - $2.87 $1.18 Million - $1.65 Million
574,000 New
574,000 $1.31 Million
Q1 2022

May 16, 2022

SELL
$3.28 - $7.12 $664,200 - $1.44 Million
-202,500 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$6.55 - $13.25 $487,975 - $987,125
-74,500 Reduced 26.9%
202,500 $1.35 Million
Q3 2021

Nov 15, 2021

BUY
$7.29 - $11.0 $2.02 Million - $3.05 Million
277,000 New
277,000 $2.51 Million

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $75.3M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.